Parkinson's Disease Trial, By Invitation NCT06750224 Sponsor: Riphah International University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT06750224
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People between 50 and 70 years of age.
  • Both men and women are included.
  • People who have been diagnosed with Parkinson's disease at a mild to moderate stage (known as Hoehn and Yahr stage 1 to 3).
  • People who are able to stand for at least 10 minutes without help from another person.
  • People who are able to walk, either on their own or with some assistance.
  • People who score higher than 24 on a standard memory and thinking test called the MMSE, indicating no significant cognitive impairment.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had a recent surgery or a bone fracture.
  • People who have problems with their vision or hearing.
  • People who have a heart or blood vessel condition that would interfere with the therapy (confirm with trial site).
  • People who have joint pain or a muscle and bone problem that would interfere with the therapy.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
1 February 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Berg balance scale; Time up and go (TUG); Fall efficacy scale-international (FES-I); Quality of life questionnaire for Parkinson's PDQ-39

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov